* Adjusted by hospital group and previous infection status
Table 4 . Two-dose CoronaVac effectiveness against symptomatic
PCR-confirmed COVID-19 infection for full cohort for entire study period
a) when re-infection could occur 60 days (rather than 90 days) after
infection; and b) when participants were considered fully vaccinated 7
days (rather than 14 days) after their second dose